Serum platelet factor 4 is a promising predictor in newly diagnosed patients with multiple myeloma treated with thalidomide and VAD regimens
Author:
Affiliation:
1. Department of Hematology, Second Affiliated Hospital, Xi’an Jiaotong University, Xi’an, People’s Republic of China
2. Department of Clinical Lab, Second Affiliated Hospital, Xi'an Jiaotong University, Xi’an, People’s Republic of China
Funder
Shaanxi Province Science and Technology Research and Development Program
Second Affiliated Hospital of Xi’an Jiaotong University
Publisher
Informa UK Limited
Subject
Hematology,Hematology
Link
https://www.tandfonline.com/doi/pdf/10.1080/16078454.2019.1592826
Reference18 articles.
1. Multiple Myeloma: Diagnosis and Treatment
2. Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management
3. Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma
4. Angiogenesis in Multiple Myeloma
5. Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Research progress of the chemokine/chemokine receptor axes in the oncobiology of multiple myeloma (MM);Cell Communication and Signaling;2024-03-12
2. Synthesis of 5, 6-diaroylisoindoline-1, 3-dione and computational approaches for investigation on structural and mechanistic insights by DFT;Molecular Simulation;2020-09-08
3. Cytokine and Chemokine Profile in Patients with Multiple Myeloma Treated with Bortezomib;Mediators of Inflammation;2020-06-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3